ANTIBIOTIC-ASSOCIATED DIARRHEA IN CLINICAL PRACTICE
https://doi.org/10.15690/vsp.v13i1.918
Abstract
Modern data on an urgent clinical problem — antibiotic-associated diarrhea — are summarized in the article. In development of antibiotic-associated diarrhea the main role is played by disturbances in microbiocenosis and immune response of the organism. Along with usage of metronidazole and vancomycin probiotics have great importance in treatment of these conditions. Probiotics also play a certain part in prevention of relapses and prophylaxis of antibiotic-associated diarrhea. Complex approach to verification of antibioticassociated diarrhea and management of patients allows significant decreasing of prevalence and severity of possible complications.
About the Authors
M. A. Osadchuk
I.M. Sechenov First Moscow State Medical University
Russian Federation
PhD, professor, Head of Polyclinic Department of I.M. Sechenov First Moscow State Medical University
Russian Federation
PhD, professor, Head of Polyclinic Department of I.M. Sechenov First Moscow State Medical University
A. A. Svistunov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. Bauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin. Microbiol. Infect. 2009; 15: 1067–1079.
2. Bauer T.M., Lalvani A., Fehrenbach J. et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospita¬lized adults. JAMA. 2001; 285: 313–319.
3. Bauer M et al. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin. Microbiol. Infect. 2009; 15: 1087–1092.
4. Cohen S.H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010; 31 (5): 2442–2249.
5. Clifford L., McDonald et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005; 353: 2442–2249.
6. Loo V.G. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005; 353: 2433–2441.
7. Shul'pekova Yu.O. Antibiotic-associated diarrhea. RMZh = Russian medical journal. 2007; 15 (6): 1–6.
8. Shchekina M.I. Role probitikov correction dysbiotic violations. Consilium medicum. Gastroenterologiya = Consilium medicum. Gastroenterology. 2009; 2: 36–42.
9. Rumyantsev V.G. Probiotics: Prospects for therapeutic application in inflammatory bowel disease. Farmateka = Pharmateca. 2009; 13: 77–79.
10. Bricker E. et al. Antibiotic treatment for C. difficile-associated diarrhea in adults. Cochr. Database Syst. Rev. 2005; 25 p.
11. Cremonini F. et al. Meta-analysis: the eff ect of probiotic administration on antibioticsso-ciated diarrhea. Aliment. Pharmacol. Ther. 2002; 16: 8.
12. Lamontagne F., Labbe A.C., Haeck O. et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann. Surg. 2007; 245: 267–272.
13. McFarland L.V. Diarrhea acquired in the hospital. Gastroenterol. Clin. North Am. 1993; 22: 563–577.
14. Zakharenko S.M. Antibiotics and probiotics competitors or synergists? Infektsion. bol. = Infectious diseases. 2007; 5 (1): 47–53.
15. Shcherbakov P.L., Nizhevich A.A., Amirova V.R. Antibiotic-associated diarrhea in children - especially correction microflora. Vopr. prakt. pediatrii = Problems of practical pediatrics. 2010; 5 (5): 24–27.
16. Bel'mer S.V. Antibiotic-associated intestinal dysbiosis. RMZh = Russian medical journal. 2004; 12 (3): 148–151.
17. Simanenkov V., Il'yashevich I., Konovalova N. Probiotic therapy in treatment of pneumonia. Vrach = The doctor. 2010; 3: 46–49.
18. Sukhorukova, M.V. .V. Timokhova, M.V. Eidel'shtein, R.S. Kozlov The sensitivity of antibiotic-resistant strains of bacteria belonging to the probiotic "Linex". Klin. mikrobiol. i antimikrob. khimioter. = Clinical microbiology and antimicrobial chemotherapy. 2012; 14 (3): 245–251.
19. Wistrom J., Norrby S.R., Myhre E.B. et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J. Antimicrob. Chemother. 2001; 47: 43–50.
20. Babcock G., Broering T., Hernandez H. et al. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect. Immun. 2006; 74: 6339–6347.
21. Allen S.J., Wareham K., Wang D. et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013; doi: 10.1016/S0140-6736(13)61218-0.
Review
For citations:
Osadchuk M.A., Svistunov A.A. ANTIBIOTIC-ASSOCIATED DIARRHEA IN CLINICAL PRACTICE. Current Pediatrics. 2014;13(1):102-108. (In Russ.) https://doi.org/10.15690/vsp.v13i1.918
Views:
1158
Email this article 
